• No results found

Systems pharmacology of the amyloid cascade

N/A
N/A
Protected

Academic year: 2021

Share "Systems pharmacology of the amyloid cascade"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/55514 holds various files of this Leiden University dissertation.

Author: Maanen, E.M.T. van

Title: Systems pharmacology of the amyloid cascade : unfolding oligomer modulation in Alzheimer's disease

Issue Date: 2017-11-23

(2)

Systems pharmacology of the amyloid cascade

Systems pharmacology of the amyloid cascade:Unfolding oligomer modulation in Alzheimer’s diseaseEline M.T. van Maanen

Unfolding oligomer modulation in Alzheimer’s disease

Eline M.T. van Maanen

Referenties

GERELATEERDE DOCUMENTEN

In the case of animal models of Parkinson's disease, the model should reproduce the main characteristics of the human disease, such as (1) selective lesion of dopaminergic neurons

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

Figure 2A: Behaviour in the subcutaneous rotenone model: The time that a rat was able to remain walking on the Rotarod at different days following implantation of the osmotic

Differences for the dopamine metabolites DOPAC and HVA between lesioned and untreated brain side were observed for baseline concentrations as well as for elimination rate

The objective of the research described in this thesis was to explore rotenone as a toxin for inducing Parkinson's disease in rats as a new rat model of this disease, and to use

Het doel van de studies beschreven in dit proefschrift was te onderzoeken of het gebruik van het neurotoxine rotenon in ratten geschikt was voor het induceren van een meer chronisch

Tijdens de doctoral fase heeft zij haar hoofdvakstage gedaan op de afdeling 'Drug Delivery Technology' van het Leiden/Amsterdam Center for Drug Research, onder begeleiding van

In geneesmiddelonderzoek zal rekening moeten worden gehouden met de bijdrage en variabiliteit van mechanismen die verantwoordelijk zijn voor de distributie van het geneesmiddel in